Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality Assurance on Diagnosis and Therapy of Secondary Immunodeficiencies (SID) in Patients With Chronic Lymphocytic Leukemia (CLL) or Multiple Myeloma (MM) in Germany (QS-SID)

NCT04172467 is registered in ClinicalTrials.gov with AIO-Studien-gGmbH as lead sponsor.

NCT NCT04172467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04172467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality Assurance on Diagnosis and Therapy of Secondary Immunodeficiencies (SID) in Patients With Chronic Lymphocytic Leukemia (CLL) or Multiple Myeloma (MM) in Germany (QS-SID)
Lead sponsor
AIO-Studien-gGmbH
Phase
Observational
Overall status
Completed
Start date
January 28, 2020
Completion date
August 3, 2020
Enrollment
1,086 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary immunodeficiencies (sid)